BRIEF published on 06/25/2025 at 08:35, 1 year ago Molten Ventures Announces Director Share Transactions London Stock Exchange Investment Molten Ventures Andrew Zimmermann Director Share Transactions
BRIEF published on 06/25/2025 at 08:35, 1 year ago Molten Ventures Executes Share Repurchase Share Repurchase Ordinary Shares Numis Securities Molten Ventures Financial Regulations
PRESS RELEASE published on 06/25/2025 at 08:30, 1 year ago Director/PDMR Shareholding Molten Ventures Plc announces Director/PDMR Shareholding transactions by CFO Andrew Zimmermann and PCA Jo-Anne Morrison on 23 June 2025 Molten Ventures Plc Director PDMR Shareholding Andrew Zimmermann Jo-Anne Morrison
PRESS RELEASE published on 06/25/2025 at 08:30, 1 year ago Transaction in Own Shares Molten Ventures plc (LSE: GROW) reports transaction in own shares by Numis Securities. Ordinary shares purchased at prices ranging from 294.20p to 299.80p Shares Molten Ventures Plc Transaction Numis Securities LSE: GROW
BRIEF published on 06/24/2025 at 08:05, 1 year ago Molten Ventures Pursues Share Repurchase Share Repurchase Ordinary Shares Molten Ventures Market Regulation Deutsche Numis
PRESS RELEASE published on 06/24/2025 at 08:00, 1 year ago Transaction in Own Shares Molten Ventures Plc (GROW) announces transaction in own shares on 23 June 2025. Numis Securities purchased 50,000 Ordinary Shares at prices ranging from 285.00p to 290.00p per share Molten Ventures Plc Own Shares GROW Transaction Numis Securities
BRIEF published on 06/23/2025 at 08:35, 1 year ago Molten Ventures Executes Share Buyback Ordinary Shares Share Buyback Financial Conduct Authority Numis Securities Molten Ventures
PRESS RELEASE published on 06/23/2025 at 08:30, 1 year ago Transaction in Own Shares Molten Ventures Plc (GROW) reports transaction in own shares with Numis Securities Ltd on 20th June 2025. 50,000 ordinary shares purchased at prices ranging from 291.60p to 296.00p Share Repurchase Molten Ventures Plc Numis Securities Ltd Transaction Details LSE: GROW
BRIEF published on 06/23/2025 at 08:05, 1 year ago Molten Ventures Plc Awards Options to PDMRs PDMR Molten Ventures LTIP Options Grant DBP
PRESS RELEASE published on 06/23/2025 at 08:00, 1 year ago Molten Ventures Plc: Grant of Options to Persons Discharging Managerial Responsibility ('PDMR') Molten Ventures PLC (LSE: GROW) grants Options to PDMRs under LTIP and DBP. Options awarded to Ben Wilkinson, Stuart Chapman, Andrew Zimmermann. Details in Annual Report Molten Ventures LTIP PDMRs Options DBP
Published on 06/29/2026 at 15:00, 10 minutes ago Infield Minerals Significantly Expands Land Holdings and Builds Regional Presence at the Detroit Gold Project in Utah
Published on 06/29/2026 at 14:30, 40 minutes ago Sekur Private Data Makes First Intl. Call on SekurOne - Launches SekurOne for Android and Web
Published on 06/29/2026 at 14:30, 40 minutes ago US FDA Has Granted A "Rare Pediatric Disease Drug" Designation for NV-387 As A Treatment for Measles - Enables Priority Review Voucher
Published on 06/29/2026 at 14:00, 1 hour 10 minutes ago First Canadian Graphite Mobilizes Field Crews to Lac Guéret South - Targeting New Kilometre-Scale Anomaly and High-Grade Zones
Published on 06/29/2026 at 14:51, 18 minutes ago NFON recognised for innovation and AI transformation: NFON named one of Germany’s most innovative medium-sized companies
Published on 06/29/2026 at 14:50, 19 minutes ago Guangdong Museum releases landmark collection series on Chinese cultural treasures
Published on 06/29/2026 at 14:45, 24 minutes ago Binzhou's Leap from Manufacturing to Intelligent Manufacturing
Published on 06/29/2026 at 14:35, 34 minutes ago Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.70 Million Tokens, and Total Crypto and Total Cash Holdings of $9.8 Billion
Published on 06/29/2026 at 10:56, 4 hours 13 minutes ago GUILLEMOT CORPORATION S.A. | Weekly report share buyback from June 22 to June 26 2026
Published on 06/26/2026 at 07:00, 3 days 8 hours ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
